GeneTherapy.ISTH.org

ISTH Gene Therapy for Hemophilia Initiative and EAHAD’s Role by ISTH

Andrew D. Leavitt, MD discusses the reliability and accessibility of gene therapy for hemophilia.

Latest Advances in Gene Therapy for Hemophilia by ISTH

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

What Do Hemophilia Treatment Centers Need to Consider for the Availability of Gene Therapy? by ISTH

Laboratory Measurement of Hemophilia Gene Therapy Products/Factor Activity by ISTH